மறுசீரமைப்பு நொதி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மறுசீரமைப்பு நொதி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மறுசீரமைப்பு நொதி Today - Breaking & Trending Today

Global Biologics Safety Testing Market Size to Grow at a

Global Biologics Safety Testing Market Size to Grow at a
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , South Korea , Microcoat Biotechnologie Gmb , Maravai Lifesciences , Lonza Bioscience , Asia Pacific , Promocell Gmb , Agilent Technologies Inc , Service Manufacturing , Almac Group , Research Academia , Burn Centers , Nelson Laboratories , Merck Kga , Technology Fusion , Pharmaceuticals Biotechnology , Associates Of Cape Cod Inc , Centers For Disease , Roche Ltd , Canadian Blood Services , Bio Rad Laboratories Inc , Merck Kgaa , Thermo Fisher Scientific Inc , For Sample Pages , Significant Market Developments Considered ,

MENA Biologics & Biosimilars Market to Surpass US$ 623.7 by 2027, Says Coherent Market Insights (CMI)

US$ 442.5 million in 2020 and is expected to exhibit a CAGR of 3.9%
during the forecast period (2020-2027).
Key Trends and Analysis:
The
MENA biologics & biosimilars market is expected to witness significant growth, owing to increasing prevalence of Age-related Macular Degeneration (AMD). For instance, according to the study in Saudi Medical Journal 2015, in Saudi Arabia, AMD represents 3.3% of the major causes of blindness in individuals older than 50 years.
The increasing approval and new drug launches are expected to propel the market growth. For instance, in 2017, Swedish Orphan Biovitrum AB (Sobi) received Saudi Food & Drug Authority (SFDA) approval for Elocta (efmoroctocog alfa), a recombinant human factor VIII Fc-fusion protein with an extended half-life, for the treatment of hemophilia A. ....

United States , United Kingdom , World Health Organization , Al Qahirah , Saudi Arabia , Asia Pacific , Chugai Pharmaceutical Co Ltd , Ministry Of Health Prevention Mo , Regeneron Pharmaceuticals Inc , Saudi Food Drug Authority , Takeda Pharmaceutical Company , Pfizer Inc , Amgen Inc , Roche Group , Business Development , Coherent Market Insights , Age Related Macular Degeneration , Saudi Medical Journal , Swedish Orphan Biovitrum , Saudi Food , Drug Authority , Middle East , Research Report , Market Takeaways , Bayti Home , Regeneron Pharmaceuticals ,